Award
National Institute of Allergy and Infectious Diseases 1R01AI198140-01
Antibody signatures of HIV treatment effectiveness: toward low-cost rapid tests for treatment monitoring
Recipient
New York University School of Medicine
Award Amount
$841,719.00
Ceiling
$841,719.00
Awarded
March 27, 2026
Identifier
1R01AI198140-01
The project aims to develop and validate low-cost rapid antibody tests to improve HIV treatment monitoring, complementing PCR testing, and to model their health impact and cost-effectiveness at individual and population levels.
Description
This project explores the development of low-cost, rapid antibody tests to monitor HIV treatment effectiveness, aiming to complement existing PCR testing. The study involves consolidating data across multiple cohorts, developing models of antibody trajectories, validating assays, and modeling strategies for individual and population-level HIV monitoring.